The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
BackgroundThe association of pro-inflammatory markers such as interleukin-6 (IL-6) and other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest, however their kinetics, response to current COVID-related treatments, association with disease severity and comparison wi...
Main Authors: | Ana Copaescu, Fiona James, Effie Mouhtouris, Sara Vogrin, Olivia C. Smibert, Claire L. Gordon, George Drewett, Natasha E. Holmes, Jason A. Trubiano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.646095/full |
Similar Items
-
Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
by: Ana Copaescu, et al.
Published: (2021-08-01) -
Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
by: Ana Copaescu, et al.
Published: (2021-09-01) -
Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
by: George P. Drewett, et al.
Published: (2021-07-01) -
An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
by: Ana Copaescu, et al.
Published: (2021-01-01) -
COVID-Care – a safe and successful digital self-assessment tool for outpatients with proven and suspected coronavirus-2019
by: George P Drewett, et al.
Published: (2021-09-01)